Bnp Paribas Arbitrage, Snc »

Lyra Therapeutics shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2025-09-30 $104 16 6.50
2025-06-30 $224 25 8.96

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Meta Platforms Equity (META)
Apple Equity (AAPL)
Tesla Equity (TSLA)
Amazon.com Equity (AMZN)
iShares Core S&P 500 ETF Fund (IVV)
Broadcom Equity (AVGO)
JPMorgan Chase & Co Equity (JPM)
Alphabet Equity (GOOGL)
SPDR S&P 500 ETF Trust Fund (SPY)
iShares Russell 2000 ETF Fund (IWM)
Alphabet Equity (GOOG)
Cisco Systems Equity (CSCO)
General Electric Equity (GE)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Lyra Therapeutics

Perceptive Advisors
Sabby Management
Vanguard Group
Ikarian Capital
Citadel Advisors
Geode Capital Management
UBS Group
Morgan Stanley
BlackRock
Royal Bank of Canada
Tower Research Capital
FMR
Signature Resources Capital Management
EverSource Wealth Advisors
Jones Financial Companies, L.L

View all funds holding Lyra Therapeutics